BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: He B, Wang Q, Liu X, Lu Z, Han J, Pan C, Carter BZ, Liu Q, Xu N, Zhou H. A novel HDAC inhibitor chidamide combined with imatinib synergistically targets tyrosine kinase inhibitor resistant chronic myeloid leukemia cells. Biomed Pharmacother 2020;129:110390. [PMID: 32563150 DOI: 10.1016/j.biopha.2020.110390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Sun Y, Cheng M, Dong L, Yang K, Ma Z, Yu S, Yan P, Bai K, Zhu X, Zhang Q. Agaricus blazei extract (FA-2-b-β) induces apoptosis in chronic myeloid leukemia cells. Oncol Lett 2020;20:270. [PMID: 32989404 DOI: 10.3892/ol.2020.12133] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Chen Y, Zou J, Cheng F, Li W. Treatment-Free Remission in Chronic Myeloid Leukemia and New Approaches by Targeting Leukemia Stem Cells. Front Oncol 2021;11:769730. [PMID: 34778088 DOI: 10.3389/fonc.2021.769730] [Reference Citation Analysis]
3 Ernst P, Heidel FH. Molecular Mechanisms of Senescence and Implications for the Treatment of Myeloid Malignancies. Cancers (Basel) 2021;13:612. [PMID: 33557090 DOI: 10.3390/cancers13040612] [Reference Citation Analysis]
4 Amir M, Javed S. A Review on the Therapeutic Role of TKIs in Case of CML in Combination With Epigenetic Drugs. Front Genet 2021;12:742802. [PMID: 34745216 DOI: 10.3389/fgene.2021.742802] [Reference Citation Analysis]
5 Mojtahedi H, Yazdanpanah N, Rezaei N. Chronic myeloid leukemia stem cells: targeting therapeutic implications. Stem Cell Res Ther 2021;12. [DOI: 10.1186/s13287-021-02659-1] [Reference Citation Analysis]